Articles
Cardiac Resynchronisation Therapy - Evolving Strategies to Enhance Response
Citation:
European Cardiology 2010;6(1):83–7
Cost-effectiveness of Gadofosveset in the Management of Patients with Symptomatic Peripheral Arterial Occlusive Disease
Citation:
European Cardiology 2008;4(1):51–7
Erratum to: The Inhibitory Effects of Crucumin Glucuronide on p300-HAT Activity and Hypertrophic Phenylephrine- Induced Responses in Cardiomyocytes
Citation:
European Cardiology Review 2018;13(2):136.
Implications of Remodelling in Atrial Fibrillation Therapy
Citation:
European Cardiology 2010;6(3):39–43
Cardiovascular Pharmacotherapy Focus
Published:
11 July 2019
Citation:
European Cardiology Review 2019;14(2):116
Response to the Comment ‘Smoking and Angiotensin-converting Enzyme Inhibitor/Angiotensin Receptor Blocker Cessation to Limit Coronavirus Disease 2019’
Published:
15 July 2020
Citation:
European Cardiology Review 2020;15:e55.
VEGF-C and Cardiovascular Mortality in Patients Undergoing Drug-eluting Stent Implantation
Citation:
European Cardiology Review 2018;13(2):124.
The GATA4 Acetylation Site Plays a Key Role in the Development of Cardiomyocyte Hypertrophy
Citation:
European Cardiology Review 2018;13(2):125.